Top Penny Stocks To Follow Now – May 17th

Virgin Galactic, Affimed, and BigBear.ai are the three Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are low-priced shares—typically trading below $5 each—of small-cap companies often listed on over-the-counter markets rather than major exchanges. These companies usually have limited operating histories and less stringent reporting requirements. Because of their low liquidity and wide price swings, penny stocks are generally considered high-risk investments. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Virgin Galactic (SPCE)

Virgin Galactic Holdings, Inc., an aerospace and space travel company, focuses on the development, manufacture, and operation of spaceships and related technologies. The company engages in the design and development, manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems for private individuals, researchers, and government agencies.

Shares of Virgin Galactic stock traded up $1.45 on Friday, hitting $4.80. The company’s stock had a trading volume of 109,271,731 shares, compared to its average volume of 2,322,506. Virgin Galactic has a 1 year low of $2.18 and a 1 year high of $23.00. The company has a market capitalization of $170.36 million, a price-to-earnings ratio of -0.28 and a beta of 2.10. The company has a debt-to-equity ratio of 1.15, a quick ratio of 4.52 and a current ratio of 4.52. The firm has a fifty day moving average price of $3.06 and a 200-day moving average price of $4.73.

Affimed (AFMD)

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany. The company’s lead product candidates include AFM13 that has completed Phase 2 clinical trial for CD30-positive lymphoma, Phase Ib clinical trial for hodgkin lymphoma, and completed Phase IIb clinical study for peripheral T-cell lymphoma; AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; and AFM28, an innate cell engager (ICE), which is in preclinical development for the treatment acute myeloid.

AFMD traded up $0.19 on Friday, hitting $0.28. 916,225,809 shares of the company’s stock were exchanged, compared to its average volume of 4,096,485. The firm has a 50-day moving average price of $0.73 and a 200-day moving average price of $1.41. The company has a current ratio of 1.93, a quick ratio of 1.93 and a debt-to-equity ratio of 0.13. Affimed has a fifty-two week low of $0.07 and a fifty-two week high of $8.95.

BigBear.ai (BBAI)

BigBear.ai Holdings, Inc. provides artificial intelligence-powered decision intelligence solutions. It offers national security, supply chain management, and digital identity and biometrics solutions. The company also provides data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics, and predictive visualization solutions and services.

Shares of NYSE:BBAI traded up $0.02 during midday trading on Friday, hitting $3.66. The company had a trading volume of 62,939,996 shares, compared to its average volume of 29,515,096. The business’s 50-day simple moving average is $3.09 and its 200-day simple moving average is $3.67. The stock has a market cap of $1.06 billion, a price-to-earnings ratio of -4.02 and a beta of 3.32. The company has a debt-to-equity ratio of 2.08, a current ratio of 2.06 and a quick ratio of 2.06. BigBear.ai has a twelve month low of $1.17 and a twelve month high of $10.36.